Ovarian Neoplasms
Ovarian Neoplasms
Ovarian Neoplasms
433OBGYNteam@gmail.com
Objectives :
⁃ Ovarian cancer is the 5th most common cause of cancer death in USA .
⁃The highest mortality rate among gynecological malignancies, 55% of patients
will die with in 5 years of diagnosis .
3.Compare between functional ovarian cysts, benign
ovarian tumors and ovarian cancers:
3.1 functional ovarian cysts
The most common cause of a simple cystic mass in the reproductive age years is a physiologic cyst (luteal or
follicular cyst). During the reproductive years the ovaries are functionally active, producing a dominant
follicle in the first half of the cycle and a corpus luteum after ovulation in the second half of the menstrual
cycle. Either of these structures, the follicular or corpus luteum, can become fluid-filled and enlarged,
producing a functional cyst.
Clinical Features :
• Follicular cyst : • Corpus luteum cyst :
- Asymptomatic - Cause pain
- Simple - Cause delayed menses
- Can reach 15 cm in diameter - Smaller than the follicular cyst
- Regress during the sub-sequent menstrual cycle
Diagnosis :
• Qualitative �-human chorionic gonadotropin (�-hCG) test: If negative, this will rule out pregnancy.
• Sonogram: A complex mass on ultrasound appearance is incompatible with a functional cyst ( if the
cyst < 10 cm , mobile and unilateral )
• Surgical exploration : If the adnexal cystic mass is solid or complex, fixed, size >10 cm and bilateral
Management :
Observation :
- If the sonogram shows a simple cyst it is probably benign but careful follow-up is needed. Follow-up
examination should be in8-12 weeks, at which time the functional cyst should have spontaneously
resolved.
- If the CA-125 titer normal and Risk for malignancy index (RMI ) is low .
Surgical exploration :
- If the cyst solid, fixed, painful and has high RMI
- In case of torsion
- Hemorrhagic cyst
Protective factors :
Oral contraceptive medication can be used to help prevent further functional cysts from forming
3.1 functional ovarian cysts
There are three histological cell types they give arise to benign ovarian
neoplasms : Serous (the most common benign neoplasms )
resembles fallopian tube epithelium
Epithelial cell types the Mutinous resembles endocervical epithelium
largest class of neoplasms Endometriod resembles carcinomas of the
endometrium.
There are three histological cell types they give arise to malignant ovarian
neoplasms :
Serous
Epithelial cell types constant Mutinous
of 90% of all ovarian malignancies Clear cell
endometriod
Dysgerminoma
Germ cell types most common
ovarian cancer in women < 20
Endodermal sinus tumor
Immature teratoma
- Pelvic transvaginal ultrasound is essential to evaluate the characteristics of the adnexal mass.
Categorization as to whether this is a simple (cystic) or complex adnexal mass is crucial to the
management.
- If cystic, mobile, and less than 10 cm, observation is reasonable in the pre-menopausal patient who is
asymptomatic (and with no family history of ovarian cancer). A repeat ultrasound in 8-12 weeks will
assist in determining if this is persistent or increasing, at which point surgical exploration would be
advisable. In this case, this is most likely a neoplasm. If the cystic ovary resolves or is smaller, then this
likely represents a functional cyst.
- If the adnexal cystic mass is solid or complex, fixed, size >10 cm, or bilateral, then surgical exploration is
recommended.
- CA125: tumor marker often elevated in women with advanced epithelial ovarian cancer. CA 125 was
developed originally to follow response to chemotherapy treatment (as surrogate marker for response),
but now used to assess for relapsed disease and to triage women with a pelvic mass (to gyn oncologist or
gynecologist for further investigations). Non-specific elevations seen among premenopausal women with
gynecologic and non-gynecologic conditions (endometriosis, fibroids, benign cystic neoplasms,
infection/inflammation, cirrhosis). More likely to be discriminating among postmenopausal women with
adnexal masses.
- Other tumor markers to consider: CEA (mucinous tumors), AFP (yolk sac germ cell tumors), LDH
(dysgerminoma), beta-HCG (choriocarcinoma, mixed germ cell tumors)
2.How would your approach be different if the patient was postmenopausal at 62 years of age?
Any postmenopausal patient with a complex cystic/solid mass requires surgical exploration and removal. If the
cyst is simple in nature, then observation is reasonable provided the patient is asymptomatic, there is no
significant family history of ovarian cancer, and CA125 is normal.
3.You obtain an ultrasound which shows a 6 cm right complex ovarian cyst. What is your differential diagnosis?
Benign:
• Functional cyst (follicular, corpus luteum, theca lutein)
• Endometrioma
• Tubo-ovarian abscess
• Serous/ uci ous cystadenoma
• Gonadal stromal tumors (fibroma/thecoma)
• Ger cell tu ors (teratomas)
Malignant:
• Epithelial tu ors (serous, uci ous, clear cell, endometrioid, Brenner)
• Ger cell tu ors (dysgerminoma, endodermal sinus tumor, immature teratoma)
• Sex cord stro al tu ors (Sertoli-Leydig, Granulosa)
4.What risk factors does this patient have for ovarian cancer?
• This patie t’s risk factors i clude a family history of ovarian cancer.
• Other risk factors include: family history breast cancer, personal history of breast cancer,
BRCA 1/2 genetic mutation, increasing age, nulliparity, infertility
• Protective factors include: oral contraceptive use, tubal ligation, increasing parity
5.List elements of the history and physical examination, which would help support the diagnosis of ovarian
cancer.